Open-label Extension to Protocol 1042-0600
NCT00512317
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
123
Enrollment
INDUSTRY
Sponsor class
Conditions
Epilepsies, Partial
Interventions
DRUG:
ganaxolone
Sponsor
Marinus Pharmaceuticals